Cefroxadine Hydrate

头孢沙定

Report date: 2026/03/10 20:00:16
NME

Base Information

Drug NameCefroxadine Hydrate
Drug Alias NameOrasporCGP-9000
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > β-lactam antibiotics > Cephalosporins antibiotics
Mechanisms of ActionCell wall inhibitorsBacterial penicillin-binding protein inhibitors
TargetsBacterial penicillin-binding protein
Therapy Area/IndicationsAcute BronchitisCystitisPyelonephritis +[12] 
Global Approved IndicationsAcute BronchitisCystitisPyelonephritis +[12] 
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved DateN/A
Country/TerritorySouth KoreaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesAlfresa Pharma
China Registration ClassN/A

Develop Information

Active CompaniesAlfresa Pharma
Inactive CompaniesN/A
Active IndicationsAcute BronchitisCystitisPyelonephritis +[12] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A